Table 2 Secondary outcomes—intention-to-treat analysis.

From: Short-term effects on physical activity level with web-based self-management support in people with COPD: a randomised controlled trial

 

COPD Web

Control

Between-group difference (95% CI)

Baseline

3 months

Within-group difference

Baseline

3 months

Within-group difference

Self-assessed PA level (3-19)

9.3 ± 4.1

11.1 ± 4.1

1.7 ± 4.4

10.0 ± 4.1

9.6 ± 3.9

−0.4 ± 4.1

1.8 (0.3, 3.4, p = 0.02)

CAT (1–40)

12.7 ± 6.4

9.0 ± 7.7

−3.6 ± 7.0

13.8 ± 6.9

9.0 ± 7.3

−4.8 ± 8.8

0.6 (−1.7, 2.8, p = 0.61)

mMRC

 0

5 (6.8)

9.1 (12.6)

 

4 (5.5)

2 .6 (3.6)

 

OR: 1.00 (0.52, 2.76, p = 0.74)

 1

37 (50.7)

34.3 (47.0)

 

32 (43.8)

35.3 (48.4)

  

 2

20 (27.4)

18.0 (24.6)

 

14 (19.2)

24.2 (33.2)

  

 3

8 (11.0)

7.4 (10.1)

 

15 (20.5)

8.2 (11.2)

  

 4

3 (4.1)

4.2 (5.7)

 

8 (11.0)

2.7 (3.7)

  

CRQ:

 Dyspnoea

5.4 ± 1.4

5.3 ± 1.4

−0.1 ± 0.9

5.3 ± 1.3

5.4 ± 1.2

0.2 ± 1.3

OR: 0.60 (0.58, 2.16, p = 0.13)

 Fatigue

4.3 ± 1.2

4.5 ± 1.4

0.2 ± 1.1

4.1 ± 1.2

4.5 ± 1.1

0.3 ± 1.3

OR: 0.89 (0.55, 2.37, p = 0.75)

 Emotion

5.2 ± 1.0

5.4 ± 1.0

0.2 ± 0.8

4.9 ± 1.1

5.2 ± 0.9

0.3 ± 1.0

OR: 1.22 (0.55, 2.45, p = 0.61)

 Mastery

5.8 ± 1.2

6.0 ± 1.2

0.2 ± 1.1

5.5 ± 2.5

5.8 ± 1.1

0.3 ± 2.3

OR: 1.01 (0.54, 2.49, p = 0.98)

  1. Baseline and 3-month data are presented as mean ± SD or n (%). Within-group-group differences are means ± SD. Between-group differences are presented as mean or odds ratio with 95% CI. CAT: COPD assessment test, higher values indicate greater impact of COPD; CRQ-SA: self-administrated chronic respiratory questionnaire, higher values indicate better health; Self-assessed PA and exercise: indicator questions according to the Swedish National Board of Health and Welfare, values of ≥11 correspond to ≥150 min of at least moderate PA/week; mMRC modified Medical Research Council dyspnoea scale, higher values indicate more dyspnoea; PA physical activity.
Back to article page